Cargando…
Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan
BACKGROUND: We investigated changes in patient characteristics, rate of sustained virologic response (SVR), and factors associated with SVR after anti-hepatitis C virus (HCV) therapy with direct-acting antiviral (DAA) regimens in real-world practice in Japan, where patients with HCV are characterize...
Autores principales: | Toyoda, Hidenori, Atsukawa, Masanori, Uojima, Haruki, Nozaki, Akito, Tamai, Hideyuki, Takaguchi, Koichi, Fujioka, Shinichi, Nakamuta, Makoto, Tada, Toshifumi, Yasuda, Satoshi, Chuma, Makoto, Senoh, Tomonori, Tsutsui, Akemi, Yamashita, Naoki, Hiraoka, Atsushi, Michitaka, Kojiro, Shima, Toshihide, Akahane, Takehiro, Itobayashi, Ei, Watanabe, Tsunamasa, Ikeda, Hiroki, Iio, Etsuko, Fukunishi, Shinya, Asano, Toru, Tachi, Yoshihiko, Ikegami, Tadashi, Tsuji, Kunihiko, Abe, Hiroshi, Kato, Keizo, Mikami, Shigeru, Okubo, Hironao, Shimada, Noritomo, Ishikawa, Toru, Matsumoto, Yoshihiro, Itokawa, Norio, Arai, Taeang, Tsubota, Akihito, Iwakiri, Katsuhiko, Tanaka, Yasuhito, Kumada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524830/ https://www.ncbi.nlm.nih.gov/pubmed/31123693 http://dx.doi.org/10.1093/ofid/ofz185 |
Ejemplares similares
-
Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response
por: Toyoda, Hidenori, et al.
Publicado: (2021) -
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study
por: Atsukawa, Masanori, et al.
Publicado: (2020) -
Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2020) -
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease
por: Kawano, Tadamichi, et al.
Publicado: (2022) -
Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2021)